Remove life
article thumbnail

Doing Life Sciences Deals in 2024

JD Supra: Mergers

Nearly one hundred life sciences professionals convened at Mintz’s Boston office last week for an event we hosted in partnership with the LES (Licensing Executives Society).

article thumbnail

Trends and Tips for Navigating Life Sciences M&A in 2024

JD Supra: Mergers

Dealmaking in the life sciences sector comes with characteristics not typically seen in more traditional mergers and acquisitions (M&A). Deals often involve negotiating around complexities associated with both the unique nature of assets of life sciences companies and the unique industry ecosystem that brings these assets to life.

M&A 159
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Antitrust in Life Sciences: A Dialogue With Anna Vernet

JD Supra: Mergers

On March 26, 2024, Skadden hosted a discussion on key developments in antitrust enforcement in the pharmaceuticals and life sciences sectors. By: Skadden, Arps, Slate, Meagher & Flom LLP

article thumbnail

Transaction Trends in Life Sciences

JD Supra: Mergers

In November, we were delighted to once again host our annual European Health & Life Sciences Symposium in Paris.

article thumbnail

5 Early Indicators Your Embedded Analytics Will Fail

Many application teams leave embedded analytics to languish until something—an unhappy customer, plummeting revenue, a spike in customer churn—demands change. But by then, it may be too late. In this White Paper, Logi Analytics has identified 5 tell-tale signs your project is moving from “nice to have” to “needed yesterday.".

article thumbnail

Dual Track Reboot: Five Key Considerations for Supercharging Your Life Science Company Exit

JD Supra: Mergers

Concurrent with the capital markets regaining momentum, 2024 to date has shown robust merger and acquisition (M&A) activity, with notable growth of close to 11% in life sciences M&A activity compared to 2023. By: McDermott Will & Emery

article thumbnail

Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q4 2023

JD Supra: Mergers

This report series examines quarterly trends in life sciences venture investment. Key findings for Q3 2023 include: Life sciences VC deal value in Q3 2023 totaled $7.7 billion, representing an uptick from last quarter across fewer deals. Total deal value has grown each quarter in 2023 for a year-to-date (YTD) total of $21.4

Finance 170
article thumbnail

The Big Payoff of Application Analytics

You’ll learn: The challenges of missing or outdated analytics How buying an analytics solution can bring new life and revenue to older applications The value of embedding analytics to users, development teams, and the bottom line